DRUG HOUSES OF AUSTRALIA (OVERSEAS LIMITED) – Trademark Portfolio

Entity Type: 03

DRUG HOUSES OF AUSTRALIA (OVERSEAS LIMITED) holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include BOSISTO'S. The owner is based in Central District.

Room 901, YIP Fong Building

9/F, No. 2 D'Aguilar Street

Central District , HK

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BOSISTO'S
BOSISTO'S
Registered 1985

Trademark Classifications

DRUG HOUSES OF AUSTRALIA (OVERSEAS LIMITED)'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does DRUG HOUSES OF AUSTRALIA (OVERSEAS LIMITED) have?

DRUG HOUSES OF AUSTRALIA (OVERSEAS LIMITED) has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does DRUG HOUSES OF AUSTRALIA (OVERSEAS LIMITED) file in?

DRUG HOUSES OF AUSTRALIA (OVERSEAS LIMITED) files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are DRUG HOUSES OF AUSTRALIA (OVERSEAS LIMITED)'s most well-known trademarks?

DRUG HOUSES OF AUSTRALIA (OVERSEAS LIMITED)'s registered trademark portfolio includes well-known marks such as BOSISTO'S. These are among 1 currently registered trademark in the portfolio.

What is DRUG HOUSES OF AUSTRALIA (OVERSEAS LIMITED)'s trademark registration success rate?

DRUG HOUSES OF AUSTRALIA (OVERSEAS LIMITED) has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.